MeSH D009164 - mycobacterium infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Isoniazid | Isoniazid |  | 1982-01-01 |  |  |
| Johnson & Johnson | Bedaquiline | Sirturo | 2026-12-01 | 2012-12-28 |  |  |
| Perrigo | Isoniazid | Isoniazid |  | 1982-01-01 |  |  |
| Roche | Isoniazid | Rimifon |  | 1982-01-01 |  |  |
| Lupin Research | Ethambutol | Ethambutol |  | 2009-06-17 |  |  |
| Rifabutin | Rifabutin |  | 2014-02-24 |  |  | |
| Sandoz | Isoniazid | Isoniazid |  | 2005-07-05 |  |  |
| Isoniazid | Nydrazid |  | 1982-01-01 |  |  | |
| Novartis | Isoniazid | Inh |  | 1982-01-01 |  |  |
| Clofazimine | Lamprene |  | 1986-12-15 |  |  | |
| Sanofi | Rifapentine | Priftin |  | 1998-06-22 |  |  |
| Isoniazid, Rifampin | Rifamate |  | 1982-01-01 |  |  | |
| Isoniazid, Rifampin, Pyrazinamide | Rifater |  | 1994-05-31 |  |  |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/1
Phase 3
88%14/16
Approved: 12Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use